ABSTRACT
BACKGROUND: The residual SYNTAX score (rSS) was designed and validated to quantify the burden of residual coronary artery disease after percutaneous coronary intervention (PCI). The aim of this study was to assess the prognostic impact of rSS in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease undergoing primary-PCI. METHODS: This retrospective cohort study included 1499 consecutive patients with STEMI who underwent primary-PCI between January 2008 and December 2015. After exclusion criteria, the multivessel disease cohort (n=535) was divided into three groups, according to rSS: complete revascularization (rSS=0; n=198), reasonable incomplete revascularization (0Subject(s)
Registries
, ST Elevation Myocardial Infarction/diagnosis
, ST Elevation Myocardial Infarction/epidemiology
, Severity of Illness Index
, Aged
, Aged, 80 and over
, Cohort Studies
, Female
, Follow-Up Studies
, Humans
, Male
, Middle Aged
, Percutaneous Coronary Intervention/methods
, Prognosis
, Retrospective Studies
, ST Elevation Myocardial Infarction/surgery
, Time Factors
, Vascular Diseases/diagnosis
, Vascular Diseases/epidemiology
, Vascular Diseases/surgery
